PS(17:0/22:2(13Z,16Z))

Metabolite details

Identifier

NGGBVCQLBMQNGN-KVIBDXDUSA-N

InChI Key

NGGBVCQLBMQNGN-KVIBDXDUSA-N

IUPAC name

(2S)-2-amino-3-[[(2R)-2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-heptadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

Preferred name

PS(17:0/22:2(13Z,16Z))

INN name

—

Synonym

—

ChEBI

CHEBI:183176

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity

Observed in differential profiles

• WT_vs_WT_Aco
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_12h_vs_Toxocara canis_12h
• Control_vs_Palmitate